Heart transplant policies underwent significant changes in 2016 and 2018, altering how hearts are allocated to patients waiting for a transplant. These changes aimed to improve survival rates and outcomes for patients on the transplant waitlist by prioritizing those with the most pressing needs. In a recent study in Circulation, researchers at Children’s Hospital of Philadelphia (CHOP) reviewed the outcomes and found some patient groups benefitted from the allocation updates, while others did not experience the same level of improvement.

Meet Matthew O’Connor, MD, Medical Director of the Heart Failure and Transplant Program at Children’s Hospital of Philadelphia (CHOP).

The co-directors of CHOP’s Cardiac Center highlight some of the biggest recent breakthroughs in pediatric cardiology along with one change they would like to see.

Katsuhide Maeda, MD, PhD, has been appointed the Surgical Director for the Heart Failure and Transplant Program and the Lung Transplant Program at Children's Hospital of Philadelphia (CHOP).

Four-year-old Zach Reesey received a second chance at life through a heart transplant.

A case study of a 13-year-old female who was diagnosed with giant cell myocarditis (GCM) and underwent a heart transplant at CHOP. She continues to be monitored for recurrence and signs of rejection.